PBIRx®
Intelligent Solutions in Pharmacy Benefits
612 Wheelers Farms Road, Milford, CT 06461
(888) 797-2479
Immediately following the March 24, 2015 notification by the FDA of a possible lethal interaction between Harvoni, Sovaldi or Sovaldi/Olysio
combination, medication treatments for Hepatitis C, with the antiarrhythmic
drug amiodarone, PBIRx developed an emergency algorithm and ran it against
their entire client database of pharmacy claims within two hours.
The results were immediately forwarded to their clients
preventing potential emergency costs to their client’s medical benefit and
their client’s employees’ quality of life. Strategic options for various clients were developed for an immediate
reach out to affected members, if any.
PBIRx's advancing technology and expertise allows
them to be very responsive when drug interactions are announced by the FDA to
develop algorithms and run them against all of their clients' pharmacy claims
data no matter which PBM currently adjudicates their claims. For over one year, PBIRx has been working with
software developers, clinicians and technology to develop cutting edge proprietary clinical algorithms poised
to manage pharmacy costs and optimize health care costs and outcomes.
PBIRx is very excited to be able to roll out their new value
added services adjunct to current PBIRx proprietary programs to clients in 2015
which will better manage both pharmacy and medical benefits costs.
No comments:
Post a Comment